Allelica provides a platform that utilizes Polygenic Risk Scores (PRS) to assess genetic risk for various diseases, enabling physicians to implement targeted preventive measures even when traditional risk factors are absent. This technology enhances clinical decision-making by integrating genetic insights into patient management, ultimately improving health outcomes across diverse populations.
Funding
$1.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
VVFounders
Product
Problem
Traditional methods of assessing disease risk often overlook the genetic component, leading to incomplete risk stratification and potentially delayed or ineffective preventive measures. This is particularly true for common diseases where genetic predisposition can significantly influence an individual's likelihood of developing a condition, even in the absence of conventional risk factors.
Solution
Allelica provides a precision medicine platform that leverages polygenic risk scores (PRS) to enhance disease risk stratification. By integrating comprehensive genetic insights into clinical practice, the platform enables physicians to identify individuals at increased genetic risk for various diseases, even when traditional risk factors are absent. This allows for more precise, evidence-based interventions and personalized care strategies, ultimately improving patient outcomes across diverse populations. The platform supports proactive management of a wide spectrum of health conditions, offering genetic insights that inform treatment decisions and optimize therapeutic approaches.
Target Audience
The primary target audience includes physicians, healthcare providers, and clinical researchers seeking to integrate genetic risk assessment into their practice to improve patient care and enable precision medicine. The platform also caters to biotech and pharmaceutical companies for streamlining genetic test development.
Features
- Multi-ancestry PRS models developed and validated across diverse populations
- Streamlined sample collection via buccal swab processed in CLIA-certified and CAP-accredited laboratories
- Personalized PRS reports quantifying genetic risk relative to a reference population
- Integration of PRS data into existing clinical workflows
- Allelica Precision Server (APS) for on-premises analysis and clinical reporting
- PREDICT module for clinical risk prediction
- DISCOVER & VALIDATE modules for research applications
- ABSOLUTEDX module for diagnostic support